Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Polyzwitterionic hydrogel electrolytes based on imidazolium cations and sulfonate anions enable stable Zn-I<sub>2</sub> batteries by regulating Zn deposition and inhibiting polyiodide shuttle.

Chemical science·2026
Same author

Mixed reality assisted target localization for transcranial magnetic stimulation navigation: a feasibility study.

Journal of neuroengineering and rehabilitation·2026
Same author

To cleave or not to cleave: a systemic evaluation of DSS versus DSSO for cross-linking mass spectrometry analysis.

Molecular systems biology·2026
Same author

[Construction of an evaluation indicator system for standardized prevention and control of type 1 diabetes mellitus].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2026
Same author

Barriers and Facilitators to Implementing Point-of-Care Ultrasound to Confirm Gastric Tube Placement in Preterm Infants: A Qualitative Study.

Journal of nursing management·2026
Same author

Metatranscriptomic discovery of a novel viral class from the Yangshan deep-water port virosphere.

Archives of virology·2026

相关实验视频

Updated: May 13, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K

基于TBK1抑制剂的结构优化

Wenxuan Sun1,2, Yuting Xie2, Qiancheng Xia1,2

  • 1Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China.

ACS medicinal chemistry letters
|April 16, 2025
PubMed
概括

研究人员使用基于结构的药物设计设计了强大的TBK1抑制剂. 一种新型的抑制剂被发现,显示出增强的免疫反应而没有自我毒性,为TBK1相关疾病提供了新的治疗途径.

科学领域:

  • 生物化学 生物化学
  • 免疫学 免疫学 免疫学
  • 药用化学 医学化学

背景情况:

  • TBK1 (TANK-binding kinase 1) 是免疫,炎症和自的关键调节者.
  • 结核基因1的失调与各种疾病有关,突出显示了其作为治疗点的潜力.

研究的目的:

  • 使用基于结构的优化方法设计和识别TBK1的强效和选择性抑制剂.
  • 为TBK1相关疾病开发新的治疗策略.

主要方法:

  • 构建和虚拟选一个针对TBK1结合部位的5,000多个化合物的集中库.
  • 分子动力学模拟和MM/PBSA结合的自由能量计算,以改进化合物选择.
  • 精选的TBK1抑制剂候选者的化学合成和生物评估.

主要成果:

  • 鉴定了一种具有775 pM的IC50的高强度TBK1抑制剂,与最初的打击 (19.57 μM) 相比显著改善.
  • 新型抑制剂支架表现出优异的酶抑制和增强的免疫中介细胞毒性.
  • 开发的抑制剂在单一使用时没有显著的细胞毒性.

结论:

  • 基于结构的药物设计对于发现强效和选择性TBK1抑制剂是有效的.

更多相关视频

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.1K

相关实验视频

Last Updated: May 13, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.1K
  • 这种新型的TBK1抑制剂是开发针对TBK1失调相关疾病的向治疗的有希望的候选者.
  • 这项研究为进一步的TBK1向治疗的临床前开发提供了坚实的基础.